For the year ending 2025-12-31, DCGO had -$54,852,529 decrease in cash & cash equivalents over the period. $29,907,536 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | -196,367,155 |
| Depreciation expense | 4,863,255 |
| Amortization of intangible assets | 5,582,601 |
| Amortization of finance lease right-of-use assets | 5,216,009 |
| Loss (gain) on disposal of assets | -39,668 |
| Deferred income tax | 7,745,066 |
| Accretion of discount related to restricted investments | 309,842 |
| Loss on equity method investments | -552,763 |
| Bad debt expense | 12,047,791 |
| Stock-based compensation | 17,442,018 |
| Loss on remeasurement of operating and finance leases | -42,367 |
| Loss on liquidation of business | 0 |
| Intangible asset impairment | 30,648,245 |
| Goodwill impairment | 58,228,096 |
| Equity investment impairment | 5,000,000 |
| Loss (gain) on change in fair value of contingent consideration | 2,056,112 |
| Accounts receivable | -112,497,747 |
| Prepaid expenses and other current assets | 3,399,532 |
| Other assets | -409,156 |
| Accounts payable | -17,640,819 |
| Accrued liabilities | -10,402,113 |
| Operating lease liabilities and right-of-use assets | 200,221 |
| Net cash provided by (used in) operating activities | 34,451,654 |
| Purchase of property and equipment | 4,544,118 |
| Purchase of intangibles | 2,890,716 |
| Acquisition of businesses, net of cash acquired | 16,394,978 |
| Purchase of restricted investments | 28,613,676 |
| Purchase of equity method investments | 4,784 |
| Purchase of equity securities | 0 |
| Proceeds from sale and maturity of restricted investments | 13,163,278 |
| Proceeds from disposal of property and equipment | 202,167 |
| Net cash used in investing activities | -39,082,827 |
| Proceeds from revolving credit line | 0 |
| Repayments of revolving credit line | 30,000,000 |
| Proceeds from notes payable | 258,700 |
| Repayments of notes payable | 41,247 |
| Due to seller | 877,713 |
| Acquisition of noncontrolling interest | 0 |
| Earnout payments on contingent liabilities | 1,952,672 |
| Distributions paid to noncontrolling interest | 175,831 |
| Proceeds from exercise of stock options | 0 |
| Payments for taxes related to shares withheld for employee taxes | 1,813,909 |
| Common stock repurchased | 10,828,906 |
| Payments on obligations under finance lease | 5,385,581 |
| Net cash (used in) provided by financing activities | -50,817,159 |
| Effect of exchange rate changes on cash and cash equivalents | 595,803 |
| Net (decrease) increase in cash, cash equivalents, restricted cash and restricted cash equivalents | -54,852,529 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period | 107,337,307 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period | 52,484,778 |
DocGo Inc. (DCGO)
DocGo Inc. (DCGO)